Meeting
2024 ASCO Quality Care Symposium
Elevating the patient voice: Understanding treatment preferences in patients with advanced prostate cancer.
Authors
Elizabeth R. Kessler
University of Colorado School of Medicine, Aurora, CO
Elizabeth R. Kessler , Elizabeth Marie Wulff-Burchfield , Jennifer Phillips , Wesley Peters , Tracy McGowan , Pankaj Aggarwal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Palliative and Supportive Care
Sub Track
Patient and Advocate Engagement
Citation
JCO Oncol Pract 20, 2024 (suppl 10; abstr 262)
DOI
10.1200/OP.2024.20.10_suppl.262
Abstract #
262
Poster Bd #
E7
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
The 340B Drug Pricing Program and oral specialty drugs for advanced prostate cancer.
First Author: Kassem S Faraj
Poster
2023 ASCO Annual Meeting
VIC regimen (vemurafenib/irinotecan/cetuximab) versus bevacizumab plus chemotherapy as first-line treatment for BRAF V600E-mutated advanced colorectal cancer.
First Author: Yijiao Chen
Poster
2023 ASCO Genitourinary Cancers Symposium
Carboplatin in metastatic castrate resistant prostate cancer: A retrospective study of heavily pretreated patients (COMPACT).
First Author: Lara Pemberton
Poster
2023 ASCO Gastrointestinal Cancers Symposium
ATM or CHEK2 alterations: Potential biomarkers of improved outcomes with irinotecan-containing chemotherapy in advanced pancreatic ductal adenocarcinoma.
First Author: Maahum Mehdi